Clinical Trials
Study Title:
A Phase 1B/2 Study of AVBS6500 in Combination with Cabozantinib, AVB S6 500 in Combination with Cabozantimib and Nivolumab, and AVB S6 500 Monotherapy in Patient with Advanced or Metastatic Clear Cell Renal Cell Carcinoma
For more information about the trial above please contact the study team:
|